We sought to explore the role of mitochondrial dysfunction in HCC tumorigenesis, and found that the human mitochondrial transcription termination factor 3 (MTERF3) localizes at 8q22.1 and is frequently amplified in HCC. This evidence concerns the gene MTERF3 and hepatocellular carcinoma.